{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:28Z","timestamp":1792785028668,"version":"4.5.0"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T00:00:00Z","timestamp":1764806400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":36,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Shaanxi key research and development program Project","award":["2023-YBSF-549"],"award-info":[{"award-number":["2023-YBSF-549"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-31035-9","type":"journal-article","created":{"date-parts":[[2025,12,4]],"date-time":"2025-12-04T01:17:19Z","timestamp":1764811039000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Bile metabolite palmitic acid augments the migration of gallbladder cancer cells through the ROS\/NF-\u043aB signaling pathway"],"prefix":"10.1038","volume":"16","author":[{"given":"Xuanbo","family":"Da","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Quanyu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingjing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiantao","family":"Mo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangju","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianzi","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zilin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Haoshang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongwei","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,4]]},"reference":[{"issue":"3","key":"31035_CR1","doi-asserted-by":"publisher","first-page":"209","DOI":"10.3322\/caac.21660","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin 71(3), 209\u2013249. https:\/\/doi.org\/10.3322\/caac.21660 (2021).","journal-title":"CA Cancer J. Clin"},{"issue":"3","key":"31035_CR2","doi-asserted-by":"publisher","first-page":"229","DOI":"10.3322\/caac.21834","volume":"74","author":"F Bray","year":"2024","unstructured":"Bray, F. et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin 74(3), 229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834 (2024).","journal-title":"CA Cancer J. Clin"},{"issue":"1","key":"31035_CR3","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1007\/s00423-008-0336-0","volume":"394","author":"T Funabiki","year":"2009","unstructured":"Funabiki, T., Matsubara, T., Miyakawa, S. & Ishihara, S. Pancreaticobiliary maljunction and carcinogenesis to biliary and pancreatic malignancy. Langenbecks Arch. Surg 394(1), 159\u2013169. https:\/\/doi.org\/10.1007\/s00423-008-0336-0 (2009).","journal-title":"Langenbecks Arch. Surg"},{"issue":"6","key":"31035_CR4","doi-asserted-by":"publisher","first-page":"1258","DOI":"10.1016\/0016-5085(85)90641-9","volume":"89","author":"K Kimura","year":"1985","unstructured":"Kimura, K. et al. Association of gallbladder carcinoma and anomalous pancreaticobiliary ductal union. Gastroenterology 89(6), 1258\u20131265. https:\/\/doi.org\/10.1016\/0016-5085(85)90641-9 (1985).","journal-title":"Gastroenterology"},{"issue":"2","key":"31035_CR5","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1002\/jhbp.421","volume":"24","author":"T Fujimoto","year":"2017","unstructured":"Fujimoto, T. et al. Elevated bile amylase level without pancreaticobiliary maljunction is a risk factor for gallbladder carcinoma. J Hepatobiliary Pancreat. Sci 24(2), 103\u2013108. https:\/\/doi.org\/10.1002\/jhbp.421 (2017).","journal-title":"J Hepatobiliary Pancreat. Sci"},{"issue":"40","key":"31035_CR6","doi-asserted-by":"publisher","first-page":"6527","DOI":"10.3748\/wjg.v12.i40.6527","volume":"28","author":"JK Sai","year":"2006","unstructured":"Sai, J. K., Suyama, M., Kubokawa, Y. & Nobukawa, B. Gallbladder carcinoma associated with pancreatobiliary reflux. World J. Gastroenterol. 28(40), 6527\u20136530. https:\/\/doi.org\/10.3748\/wjg.v12.i40.6527 (2006).","journal-title":"World J. Gastroenterol."},{"issue":"8","key":"31035_CR7","doi-asserted-by":"publisher","first-page":"953","DOI":"10.3748\/wjg.v17.i8.953","volume":"28","author":"MA Beltran","year":"2011","unstructured":"Beltran, M. A. Pancreaticobiliary reflux in patients with a normal pancreaticobiliary junction: pathologic implications. World J. Gastroenterol. 28(8), 953\u2013962. https:\/\/doi.org\/10.3748\/wjg.v17.i8.953 (2011).","journal-title":"World J. Gastroenterol."},{"issue":"5","key":"31035_CR8","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1007\/s00534-013-0606-2","volume":"20","author":"Y Morine","year":"2013","unstructured":"Morine, Y. et al. Clinical features of pancreaticobiliary maljunction: update analysis of 2nd Japan-nationwide survey. J Hepatobiliary Pancreat. Sci. 20(5), 472\u2013480. https:\/\/doi.org\/10.1007\/s00534-013-0606-2 (2013).","journal-title":"J Hepatobiliary Pancreat. Sci."},{"issue":"6","key":"31035_CR9","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.3892\/or.10.6.1693","volume":"10","author":"A Tsuchida","year":"2003","unstructured":"Tsuchida, A., Itoi, T., Aoki, T. & Koyanagi, Y. Carcinogenetic process in gallbladder mucosa with pancreaticobiliary maljunction (Review). Oncol Rep. 10(6), 1693\u20131699. https:\/\/doi.org\/10.3892\/or.10.6.1693 (2003).","journal-title":"Oncol Rep."},{"issue":"1","key":"31035_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1186\/s12944-021-01527-4","volume":"31","author":"Y Xiang","year":"2021","unstructured":"Xiang, Y. et al. Free fatty acids and triglyceride change in the gallbladder bile of gallstone patients with pancreaticobiliary reflux. Lipids Health Dis. 31(1), 97. https:\/\/doi.org\/10.1186\/s12944-021-01527-4 (2021).","journal-title":"Lipids Health Dis."},{"issue":"1","key":"31035_CR11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12876-023-03097-4","volume":"2","author":"X Da","year":"2024","unstructured":"Da, X. et al. Identification of changes in bile composition in pancreaticobiliary reflux based on liquid chromatography\/mass spectrometry metabolomics. BMC Gastroenterol. 2(1), 5. https:\/\/doi.org\/10.1186\/s12876-023-03097-4 (2024).","journal-title":"BMC Gastroenterol."},{"issue":"1","key":"31035_CR12","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2017.01.051","volume":"26","author":"MJ Binker-Cosen","year":"2017","unstructured":"Binker-Cosen, M. J. et al. Palmitic acid increases invasiveness of pancreatic cancer cells AsPC-1 through TLR4\/ROS\/NF-kappaB\/MMP-9 signaling pathway. Biochem Biophys. Res. Commun. 26(1), 152\u2013158. https:\/\/doi.org\/10.1016\/j.bbrc.2017.01.051 (2017).","journal-title":"Biochem Biophys. Res. Commun."},{"key":"31035_CR13","doi-asserted-by":"publisher","first-page":"10230","DOI":"10.1038\/ncomms10230","volume":"12","author":"V Laurent","year":"2016","unstructured":"Laurent, V. et al. Periprostatic adipocytes act as a driving force for prostate cancer progression in obesity. Nat Commun. 12, 10230. https:\/\/doi.org\/10.1038\/ncomms10230 (2016).","journal-title":"Nat Commun."},{"issue":"7","key":"31035_CR14","doi-asserted-by":"publisher","first-page":"2455","DOI":"10.1158\/0008-5472.CAN-10-3323","volume":"1","author":"B Dirat","year":"2011","unstructured":"Dirat, B. et al. Cancer-associated adipocytes exhibit an activated phenotype and contribute to breast cancer invasion. Cancer Res. 1(7), 2455\u20132465. https:\/\/doi.org\/10.1158\/0008-5472.CAN-10-3323 (2011).","journal-title":"Cancer Res."},{"issue":"7635","key":"31035_CR15","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature20791","volume":"5","author":"G Pascual","year":"2017","unstructured":"Pascual, G. et al. Targeting metastasis-initiating cells through the fatty acid receptor CD36. Nature 5(7635), 41\u201345. https:\/\/doi.org\/10.1038\/nature20791 (2017).","journal-title":"Nature"},{"issue":"2","key":"31035_CR16","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/j.jhep.2017.03.017","volume":"67","author":"W Xu","year":"2017","unstructured":"Xu, W. et al. O-GlcNAc transferase promotes fatty liver-associated liver cancer through inducing palmitic acid and activating Endoplasmic reticulum stress. J Hepatol. 67(2), 310\u2013320. https:\/\/doi.org\/10.1016\/j.jhep.2017.03.017 (2017).","journal-title":"J Hepatol."},{"key":"31035_CR17","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.freeradbiomed.2018.08.024","volume":"126","author":"H Su","year":"2018","unstructured":"Su, H. et al. Procyanidin B2 ameliorates free fatty acids-induced hepatic steatosis through regulating TFEB-mediated lysosomal pathway and redox state. Free Radic Biol. Med. 126, 269\u2013286. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2018.08.024 (2018).","journal-title":"Free Radic Biol. Med."},{"key":"31035_CR18","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1016\/j.biopha.2018.09.049","volume":"108","author":"Q Chen","year":"2018","unstructured":"Chen, Q. et al. Astragalosides IV protected the renal tubular epithelial cells from free fatty acids-induced injury by reducing oxidative stress and apoptosis. Biomed Pharmacother. 108, 679\u2013686. https:\/\/doi.org\/10.1016\/j.biopha.2018.09.049 (2018).","journal-title":"Biomed Pharmacother."},{"issue":"2","key":"31035_CR19","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1111\/bph.14079","volume":"175","author":"Y Sun","year":"2018","unstructured":"Sun, Y. et al. Berberine attenuates hepatic steatosis and enhances energy expenditure in mice by inducing autophagy and fibroblast growth factor 21. Br J. Pharmacol. 175(2), 374\u2013387. https:\/\/doi.org\/10.1111\/bph.14079 (2018).","journal-title":"Br J. Pharmacol."},{"issue":"3","key":"31035_CR20","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1245\/s10434-018-07132-7","volume":"26","author":"S Nakada","year":"2019","unstructured":"Nakada, S. et al. Roles of Pin1 as a key molecule for EMT induction by activation of STAT3 and NF-kappaB in human gallbladder cancer. Ann Surg. Oncol. 26(3), 907\u2013917. https:\/\/doi.org\/10.1245\/s10434-018-07132-7 (2019).","journal-title":"Ann Surg. Oncol."},{"issue":"7","key":"31035_CR21","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1007\/s12032-017-0980-8","volume":"34","author":"E Prieto-Garcia","year":"2017","unstructured":"Prieto-Garcia, E., Diaz-Garcia, C. V., Garcia-Ruiz, I. & Agullo-Ortuno, M. T. Epithelial-to-mesenchymal transition in tumor progression. Med Oncol. 34(7), 122. https:\/\/doi.org\/10.1007\/s12032-017-0980-8 (2017).","journal-title":"Med Oncol."},{"issue":"1","key":"31035_CR22","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1186\/s13046-019-1250-8","volume":"10","author":"H Shen","year":"2019","unstructured":"Shen, H. et al. PLEK2 promotes gallbladder cancer invasion and metastasis through EGFR\/CCL2 pathway. J Exp. Clin. Cancer Res. 10(1), 247. https:\/\/doi.org\/10.1186\/s13046-019-1250-8 (2019).","journal-title":"J Exp. Clin. Cancer Res."},{"issue":"1","key":"31035_CR23","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s40164-024-00550-2","volume":"13","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. M2-like tumor-associated macrophage-secreted CCL2 facilitates gallbladder cancer stemness and metastasis. Exp Hematol. Oncol. 13(1), 83. https:\/\/doi.org\/10.1186\/s40164-024-00550-2 (2024).","journal-title":"Exp Hematol. Oncol."},{"key":"31035_CR24","doi-asserted-by":"publisher","first-page":"17069","DOI":"10.1038\/cddiscovery.2017.69","volume":"3","author":"S Xu","year":"2017","unstructured":"Xu, S., Zhan, M. & Wang, J. Epithelial-to-mesenchymal transition in gallbladder cancer: from clinical evidence to cellular regulatory networks. Cell. Death Discov. 3, 17069. https:\/\/doi.org\/10.1038\/cddiscovery.2017.69 (2017).","journal-title":"Cell. Death Discov"},{"issue":"2","key":"31035_CR25","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.bbadis.2016.11.005","volume":"1863","author":"SM Ahmed","year":"2017","unstructured":"Ahmed, S. M., Luo, L., Namani, A., Wang, X. J. & Tang, X. Nrf2 signaling pathway: pivotal roles in inflammation. Biochim Biophys. Acta Mol. Basis Dis. 1863(2), 585\u2013597. https:\/\/doi.org\/10.1016\/j.bbadis.2016.11.005 (2017).","journal-title":"Biochim Biophys. Acta Mol. Basis Dis."},{"key":"31035_CR26","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222413181","author":"J Chung","year":"2021","unstructured":"Chung, J. et al. Correlation between oxidative stress and transforming growth factor-beta in cancers. Int J. Mol. Sci. https:\/\/doi.org\/10.3390\/ijms222413181 (2021).","journal-title":"Int J. Mol. Sci."},{"issue":"5","key":"31035_CR27","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/gut.2007.141986","volume":"57","author":"F Marra","year":"2008","unstructured":"Marra, F. Nuclear factor-kappaB Inhibition and non-alcoholic steatohepatitis: inflammation as a target for therapy. Gut 57(5), 570\u2013572. https:\/\/doi.org\/10.1136\/gut.2007.141986 (2008).","journal-title":"Gut"},{"issue":"1","key":"31035_CR28","doi-asserted-by":"publisher","first-page":"e99","DOI":"10.1016\/j.jss.2010.05.058","volume":"164","author":"J Wang","year":"2010","unstructured":"Wang, J. et al. Correlation of Nrf2, HO-1, and MRP3 in gallbladder cancer and their relationships to clinicopathologic features and survival. J Surg. Res. 164(1), e99-105. https:\/\/doi.org\/10.1016\/j.jss.2010.05.058 (2010).","journal-title":"J Surg. Res."},{"key":"31035_CR29","doi-asserted-by":"publisher","first-page":"1184079","DOI":"10.3389\/fonc.2023.1184079","volume":"13","author":"L Lin","year":"2023","unstructured":"Lin, L. et al. Nrf2 signaling pathway: current status and potential therapeutic targetable role in human cancers. Front. Oncol. 13, 1184079. https:\/\/doi.org\/10.3389\/fonc.2023.1184079 (2023).","journal-title":"Front. Oncol."},{"issue":"1","key":"31035_CR30","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/1756-9966-31-66","volume":"19","author":"L Zhang","year":"2012","unstructured":"Zhang, L. et al. Propofol induces proliferation and invasion of gallbladder cancer cells through activation of Nrf2. J Exp. Clin. Cancer Res. 19(1), 66. https:\/\/doi.org\/10.1186\/1756-9966-31-66 (2012).","journal-title":"J Exp. Clin. Cancer Res."},{"key":"31035_CR31","doi-asserted-by":"publisher","first-page":"101149","DOI":"10.1016\/j.redox.2019.101149","volume":"22","author":"L Tian","year":"2019","unstructured":"Tian, L. et al. aPKCiota promotes gallbladder cancer tumorigenesis and gemcitabine resistance by competing with Nrf2 for binding to Keap1. Redox Biol. 22, 101149. https:\/\/doi.org\/10.1016\/j.redox.2019.101149 (2019).","journal-title":"Redox Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31035-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31035-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T21:03:45Z","timestamp":1768165425000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-31035-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,4]]},"references-count":31,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["31035"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-31035-9","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,4]]},"assertion":[{"value":"22 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1262"}}